Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCG therapy for sperm retrieval in men with non-obstructive azoospermia
IRCT20240222061085N1Phase 2Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, double-blind trial of human chorionic gonadotropin in male infertility and nonobstructive azoospermia (NOA) (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Help to improve infertility, Average number of motile sperm in semen before and after HCG therapy and 5 more. Started Mar 2024; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
male infertilitynonobstructive azoospermia (NOA)
Beyond the preview
Go deeper on IRCT20240222061085N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240222061085N1.